BEHIND THE BLUR

Retrophin, Inc.

Application Filed: 2020-11-03

Trademark Application Details

Mark For: BEHIND THE BLUR® trademark registration is intended to cover the categories of genetic testing for medical purposes; providing information in the field of screening, diagnosis and treatment of Cerebrotendinous Xanthomatosis (CTX). [all]

Status

2020-11-07 UTC

LIVE APPLICATION Awaiting Examination

The trademark application has been accepted by the Office (has met the minimum filing requirements) and has not yet been assigned to an examiner.

Research	OneLook Acronym Finder
Serial Number	90296726
Registration Number	6434157
Mark Literal Elements	BEHIND THE BLUR
Mark Drawing Type	4 - STANDARD CHARACTER MARK
Mark Type	SERVICE MARK
Register	PRINCIPAL
Current Location	NEW APPLICATION PROCESSING 2020-11-06
Basis	1(a)
Class Status	ACTIVE
Primary US Classes	100: Miscellaneous 101: Advertising and Business
Primary International Class	044 - Primary Class (Medical, beauty & agricultural) Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
Filed Use	Yes
Current Use	Yes
Intent To Use	No
Filed ITU	No
44D Filed	No
44E Current	No
66A Current	No
Current Basis	No
No Basis	No
Attorney Name	Jared M. Barrett
Attorney Docket Number	790116.320

Timeline

2020-09-00	Date of First Use
2020-09-01	Date of First Use
2020-09-01	Date of Use In Commerce
2020-11-03	Application Filed
2020-11-06	Location: NEW APPLICATION PROCESSING
2020-11-06	Status: Live/Pending
2020-11-06	Status: New application will be assigned to an examining attorney approximately 3 months after filing date.
2020-11-06	Transaction Date
2021-07-27	Trademark Registered

Trademark Parties (Applicants & Owners)

Party:	Retrophin, Inc.
Address	Suite 200 3721 Valley Centre Drive San Diego, CALIFORNIA UNITED STATES 92130
Legal Entity Type	Corporation
Legal Entity State	DELAWARE

Documents

Application	MULTI	2020-11-03
Drawing	JPEG	2020-11-03
Specimen	JPEG	2020-11-03

Attorney of Record

JARED M. BARRETT
SEED IP LAW GROUP LLP
701 FIFTH AVENUE
SUITE 5400
SEATTLE, WA 98104

Good, Services, and Codes

IC 044. US 100 101. G & S: Genetic testing for medical purposes; providing information in the field of screening, diagnosis and treatment of Cerebrotendinous Xanthomatosis (CTX). FIRST USE: 20200900. FIRST USE IN COMMERCE: 20200900

International Codes:	44
U.S. Codes:	100,101

Type Code	Type
GS0441	Genetic testing for medical purposes; providing information in the field of screening, diagnosis and treatment of Cerebrotendinous Xanthomatosis (CTX)
GS0441	Genetic testing for medical purposes; providing information in the field of screening, diagnosis and treatment of Cerebrotendinous Xanthomatosis (CTX)

Trademark Filing History

Description	Date	Proceeding Number
NEW APPLICATION ENTERED IN TRAM	2020-11-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.